Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease; Patients suffering from acute coronary syndrome: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention; ST segment elevation acute myocardial infarction, in medically treated patients eligible for thrombolytic therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
